免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

LEXURE for Post-Stroke Aphasia

NCT:NCT07570264 · RECRUITING

NCT IDNCT07570264
狀態RECRUITING
開始日期2026-04-16
完成時間2026-12-30
SponsorNunaps Inc (INDUSTRY)
First posted
Last updated

簡要摘要

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑